3[1]Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events[J]. JAMA. 1995,274(1):35.
4[2]Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit[J]. JAMA. 1999 ,282(3):267.
5[3]Bates DW, Leape LL, Culen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors[J]. JAMA, 1998,280(15): 1311.
6[4]Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J]. Clin Phar Ther,1981,30(2):239～45.
7[5]Report of the Quality Interagency Coordination Task Force (QUIC). Doing what counts for patient safety: Federal actions to reduce medical errors and their impact[J]. 2002; February: 37.
8[6]Classen DC, Pestotnik SL, Evars RS, et al. Adverse drug events in hospitalized patients[J]. JAMA, 1997, 277(17):301.
9[7]Miyagawa CI, Rivera JO. Effect of pharmacist intervention on drug therapy at a surgical intensive care unit[J]. Am J Hosp Pharm, 1986,43(5):3008.
10Pezalla E.Preventing adverse drug reactions in the general population[J]. Manag Care Interface, 2005,18(10) :49.
